25 May 2013
Keywords: gsk, drops, licenses, drugs, deals, worth, million
Article | 22 April 2002
GlaxoSmithKline has decided not to continue development of afluoroquinolone antibiotic, Factive (gemifloxacin), which it licensed
from South Korean company LG ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 April 2002
15 April 2002
24 May 2013
© 2013 thepharmaletter.com